By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Gulf PressGulf Press
  • Home
  • Gulf News
    • Saudi Arabia
    • UAE24/7
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • World
  • Business
    • Market DataLive
    • Finance
    • Economy
    • Energy
    • Crypto
    • ForexHot
    • Tech
  • Sports
  • Lifestyle
  • Videos
Search
Countries
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Bahrain
  • Oman
More Topics
  • Technology
  • Health
  • Entertainment
  • Crypto
  • Forex
  • Stocks
Site Links
  • Business Hub
  • Trending
  • Weather
  • Customize Interests
  • Bookmarks
  • Newsletter
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Reading: Use of diabetes medications such as Ozempic may lower the chances of developing 10 different types of cancer.
Share
Notification Show More
Latest News
UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech
Beat the Heat This Summer with a Chill Out on Dubai Marina
World
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World
Jordan to Host Iraq in the Final Round of the Asian World Cup Qualifiers After Securing Historic Spot
Sports
Aa
Gulf PressGulf Press
Aa
  • Gulf News
  • World
  • Business
  • Entertainment
  • Lifestyle
  • Sports
  • Videos
Search
  • Home
    • Videos
    • Business Hub
    • Trending
  • Gulf
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • Business
    • Market Data
    • Crypto
    • Economy
    • Energy
    • Finance
    • Forex
    • Tech
  • More News
    • World
    • Lifestyle
    • Entertainment
    • Sports
Have an existing account? Sign In
Follow US
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Gulf Press > Health > Use of diabetes medications such as Ozempic may lower the chances of developing 10 different types of cancer.
Health

Use of diabetes medications such as Ozempic may lower the chances of developing 10 different types of cancer.

News Room
Last updated: 2024/07/12 at 4:53 PM
News Room
Share
3 Min Read
SHARE

Obesity is a major risk factor for developing certain types of cancer. Researchers are actively studying ways to decrease the risk of obesity-associated cancers. A recent study found that individuals with type 2 diabetes who were treated with glucagon-like peptide receptor agonists (GLP-1RAs) had a reduced risk for 10 different obesity-associated cancers. This has significant implications for diabetes management and cancer prevention.

In the study published in JAMA Network Open, researchers compared three groups of individuals with type 2 diabetes: those taking GLP-1RAs, insulin, and metformin. Participants on GLP-1RAs showed a significant risk reduction for 10 out of 13 obesity-associated cancers compared to those taking insulin. This suggests that GLP-1RAs may play a role in preventing certain types of cancer associated with obesity.

Having obesity or being overweight can increase the risk for various conditions, including thyroid, pancreatic, colon, breast, and liver cancer. Excess body fat can lead to chronic inflammation, insulin resistance, altered levels of sex hormones, and other factors that promote tumor development and progression. Doctors recommend healthy diets, increased physical activity, and appropriate cancer screening to lower the risk of obesity-related cancers.

This retrospective observational study analyzed over 1.6 million people with type 2 diabetes and no history of obesity-associated cancers. Participants prescribed GLP-1RAs had a lower risk for ten obesity-associated cancers compared to those prescribed insulin. The study also highlighted the importance of further research to understand the mechanisms by which GLP-1RAs exert protective effects and to confirm the results using other electronic health records databases.

While the study supports the potential benefits of GLP-1RAs in lowering cancer risks, there are limitations to consider. Electronic health records may contain errors and biases, and researchers were unable to control for variables after participants’ first prescription. Future research is needed to explore potential risks associated with GLP-1RAs, such as an increased risk for thyroid cancer. It is crucial to continue studying the relationship between diabetes treatment approaches and cancer prevention.

Dr. Anton Bilchik, a surgical oncologist, emphasized the importance of incorporating exercise, nutrition, and weight loss in reducing cancer risk. While GLP-1 drugs may help prevent obesity-related cancers, they should not replace established preventive measures. The study’s findings highlight the complex interplay between obesity, diabetes, and cancer risk, underscoring the need for comprehensive approaches to health management.

In conclusion, the study provides valuable insights into the potential benefits of GLP-1RAs in reducing the risk of obesity-associated cancers in individuals with type 2 diabetes. By understanding the connections between obesity, diabetes, and cancer, researchers and healthcare providers can develop more effective strategies for cancer prevention and management. Further research is essential to validate these findings and explore additional avenues for reducing cancer risks in at-risk populations.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room July 12, 2024
Share this Article
Facebook Twitter Copy Link Print
Previous Article Check out: Dubai influencer attends world’s most extravagant wedding – News
Next Article India: Vizhinjam Port Greets its First Mothership
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3k Followers Like
69.1k Followers Follow
56.4k Followers Follow
136k Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports July 6, 2025
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech July 1, 2025
Beat the Heat This Summer with a Chill Out on Dubai Marina
World July 1, 2025
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World June 28, 2025

You Might also Like

Health

Mindfulness could be equally effective as antidepressants

October 17, 2024
Health

What is the impact of caffeine on the risk of developing diseases?

October 17, 2024
Health

Scientists discover combination of 14 genes that enhance outcomes

October 16, 2024
Health

Seizure medication demonstrates potential in individuals with no genetic risk

October 16, 2024
Health

Heart disease increases risk, heparin can postpone onset

October 16, 2024
Health

What type of breakfast is most effective for weight loss in women compared to men?

October 15, 2024
Health

How does the brain remove “waste” to protect itself?

October 14, 2024
Health

How does stress, sleep, and gut imbalances affect it?

October 13, 2024
//

Gulf Press is your one-stop website for the latest news and updates about Arabian Gulf and the world, follow us now to get the news that matters to you.

Quick Link

  • Privacy Policy
  • Terms of ue
  • Advertise
  • Contact

How Topics

  • Gulf News
  • International
  • Business
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our latest news instantly!

I have read and agree to the terms & conditions
Gulf PressGulf Press
Follow US

© 2023 Gulf Press. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?